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Abstract
Purpose of Review This paper discusses the current issues in the development of foetal charts and is informed by a scoping
review of studies constructing charts between 2012 and 2018.
Recent Findings The scoping review of 20 articles revealed that there is still a lack of consensus on how foetal charts should be
constructed and whether an international chart that can be applied across populations is feasible. Many of these charts are in
clinical use today and directly affect the identification of at risk newborns that require treatment and nutritional strategies.
However, there is no agreement on important design features such as inclusion and exclusion criteria; sample size and agreement
on definitions such as what constitutes a healthy population of pregnant women that can be used for constructing foetal standards.
Summary This paper therefore reiterates some of these current issues and the scoping review showcases the heterogeneity in the
studies developing foetal charts between 2012 and 2018. There is no consensus on these pertinent issues and hence if not resolved
will lead to continued surge of foetal reference and standard charts which will only exacerbate the current problem of not being
able to make direct comparisons of foetal size and growth across populations.
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Introduction
A reference or standard chart depicts a family of curves
representing a few selected centiles of the distribution of some
physical characteristic of the reference population as a function of
age. Such charts allow an individual to be placed in the context of
like individuals. Charts of measurements are useful for assessing
humans at all stages: foetuses, neonates, children and adults.
Adolphe Quetelet (1796–1874) was the first to investigate the
statistical properties of anthropometry and apply the concept of
the normal distribution to anthropometry data [1]. Francis Galton
(1822–1911) introduced the use of percentile scores for
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Important points:
- A scoping review of 20 studies between 2012 and 2018 showed several
differences in the design considerations and methodologies for the
development of foetal charts.
- Important study design features requiring consideration to produce these
charts include: the type of approach, the sampling methods, the sample
size and the definition of a healthy population of women.
- The current point arousing much debate around the construction of
foetal growth charts is whether ethnicity plays a role in foetal growth
and if it should be taken into account during the creation of these charts.
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comparingmeasurements with the normal distribution using data
on attained height from birth to adulthood [2]. A first application
of this approach was in growth in height, which is normally
distributed from birth to adulthood conditional on age.
Foetal growth monitoring during pregnancy has been an
important practice amongst obstetricians usually done to ascer-
tain the health status of a foetus and relevant interventions may
be provided when the health of a foetus is compromised [3, 4].
Growth charts are intended to aid clinical judgements. Foetal
growth charts are primarily used: to compare the size of a foetus
with reference data when gestational age (GA) is known at a
specified time [5••]; to estimate GA from foetal size (e.g.,
crown-rump length and foetal head circumference are common-
ly used for this purpose) [6–8]; and to assess a foetus’ rate of
growth between two time points (velocity) [9, 10]. For exam-
ple, a foetus classified as being > 97th centile according to an
estimated foetal weight chart would prompt clinicians to either
deliver early or consider a caesarean section to avoid complica-
tions that may be associated with delivering a large baby.
The systematic review of 83 published reference charts of
foetal biometry across 32 countries identified in 2012 by
Ioannou et al. revealed wide variations between the centile
values reported by published studies. There was considerable
methodological heterogeneity: the charts were based on dif-
ferent populations and created with different sample selection,
methodology and statistical modelling methods [11]. The
availability of many charts in use is problematic as it has been
shown that the choice of a reference chart in a particular set-
ting could have great impact on the assessment of foetal bio-
metric assessments [3, 12]. For example, a study by Salomon
et al. evaluated the impact of using different charts and report-
ed between 2.6 and 23.6% of measurements would be classi-
fied as abnormal using three different charts of foetal biometry
that are commonly used [12]. Due to these differences in the
data used in the creation of each foetal growth chart, compar-
isons between them are difficult.
These differences in foetal growth charts with the need to
be able to make direct comparisons were the motivation for
theWorldHealthOrganisation (WHO) in 1995 to advocate for
the creation of a single universal chart that could be used
globally to assess foetal and child growthwhich reflects recent
health and feeding recommendations of different populations
and settings [13]. This recommendation attracted several de-
bates over the varying effects of various factors like environ-
mental and genetic influences on foetal growth [14].
However, regardless of which growth chart is used clinically,
there are design and methodological constructs that must be
taken into consideration. To understand and summarise current
issues in the developments of foetal references and standards,
we did a quick review (by no means exhaustive) of studies
published between 2012 and 2018 whose aim was to construct
foetal references or standards. The review was aimed at under-
standing and highlighting the current debates and schools of
thought regarding the development of foetal growth references
and standards.We focussed on studies in the last 5 years as they
represent a time period where three large prospective studies
purposely designed to construct foetal growth charts for wide
use were published i.e., the international foetal charts from the
INTERGROWTH-21st Project [5••], the WHO foetal growth
charts intended for international application [32••] and the
National Institute of Child Health and Human Development
foetal charts that were ethnic specific [15••].
Scoping Review
Search Strategy
We searched MEDLINE via PubMed from January 2012 to
April 2018 to identify studies that constructed foetal growth
charts for foetal growth assessment. The search strategy used
was adapted from a previous systematic review by Ioannou
et al. [11] shown in Table 1. In addition, reference lists of all
articles included were similarly searched for potential relevant
articles. The search included book chapters and documents
from organisations such as WHO and the United States
Centers for Disease Control and Prevention (CDC) but ex-
cluded abstracts from conference proceedings. The initial
search yielded 180 articles. After a review of the titles and
abstracts, 27 articles were selected for a closer consideration.
From the 27 articles, 20 studies produced foetal growth refer-
ences or standards. A summary of the characteristics of the
included studies are shown in Table 2 with details on study
designs used and the intended purpose of the study.
Summary Findings from the Scoping Review
Of the 20 studies, three aimed to develop international foetal
s tandards and were al l longi tudinal studies ( the
INTERGROWTH-21st Project, the NICHD Fetal Growth
Studies and the WHO Fetal Study). Two of the three studies
which established standards (the INTERGROWTH 21st
Project and the WHO Fetal Study were done in multiple
Table 1 Search strategy [11]
Search strategy
(((fetal OR foetal OR fetus OR foetus) AND growth) OR ((fetal OR foetal
OR fetus OR foetus) AND biometr*)) OR (reference adj (curve* OR
chart* OR index OR indices OR equation* OR value* OR range* OR
equation* OR centile* OR percentile*)) OR (biometr* adj (curve* OR
chart* OR index OR indices OR equation* OR value* OR range* OR
equation* OR centile* OR percentile*)) OR (size adj (chart* OR
curve*)) OR (dating adj (curve* OR chart*))*Reference
Values/Ultrasonography, Prenatal/(ultrasound* OR ultrasonogra* OR
sonogra*)
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countries whilst the NICHD Fetal Growth Study was done
only in the USA. The other 17 studies were done in single
countries: four in Europe, four in Asia, three in North
America, four in South America, one in the Middle East and
one in North Africa. The purpose of the study by Dias et al.
[18] was not clear and the remaining 16 studies produced
foetal reference charts. Four of the 16 studies, which
established references, were also longitudinal studies [11,
15••, 20, 22] whilst the remaining 12 studies were all based
on a cross-sectional design.
Five studies established references for twins and 11 studies
included healthy populations in their samples. The definition of
healthy populations varied greatly amongst these studies making
comparisons difficult. For example, Dias et al. defined healthy
pregnant women as those who did not have a relevant past med-
ical history; were not on long termmedications; had no evidence
of socio-economic constraints likely to impede foetal growth; no
use of tobacco, recreational drugs or alcohol use; no evidence of
urinary tract infections or renal disease on urinalysis; had a sys-
tolic blood pressure < 140 mmHg and diastolic blood pressure <
90 mmHg; no diagnosis or treatment for anaemia during preg-
nancy and not in an occupation with risk of exposure to
chemicals or toxic substances [18]. Xu et al. included women
without pre-pregnancy diabetes, pre-pregnancy hypertension,
non-smokers during pregnancy, no alcohol consumption during
pregnancy, self-reported pre-pregnancy body mass index (BMI)
≥ 17 kg/m2 or < 27 kg/m2, no pre-eclampsia and/or pregnancy-
induced hypertension and non-diabetics [19]. Briceño et al. in-
cluded women without maternal disease that may have affected
foetal growth, such as hypertension, preeclampsia, diabetes
mellitus and renal disease [3] which was similar to the inclusion
criteria of Araujo Júnior et al. (women with absence of maternal
diseases and absence of foetal malformations on sonography)
[22]; Jiang et al. (women without maternal diseases, such as
hypertension, pre-eclampsia, diabetes mellitus, renal disease;
multiple pregnancies; and foetuses without congenital
malformations, chromosomal abnormalities or intrauterine
growth retardation) [27] and Kwon et al. (women without ma-
ternal disease possibly affecting foetal growth such as hyperten-
sion, diabetes mellitus and renal disease) [24], whilst Liao et al.
included women with uncomplicated pregnancies [20]. Moety
et al. also included only women who did not smoke and those
without chronic diseases such as chronic hypertension or diabetes
mellitus or give history of recurrent abortions [31].
Similarly, the three large prospective studies that developed
foetal standards differed in their definition of what they consid-
ered as healthy women. In brief, the NICHD Fetal Growth
Studies carried out by Buck Louis et al. excluded: women who
smoked cigarettes or used illicit drugs in the past 6 or 12 months;
who drunk ≥ 1 daily alcoholic drinks; had previous foetal con-
genital malformation; a history of non-communicable diseases
(asthma requiring weekly medication, autoimmune disorders,
cancer, diabetes mellitus, epilepsy or seizures requiring
medication, hematologic disorders, hypertension, psychiatric dis-
orders, renal disease and thyroid disease) or history of gravid
diseases (gestational diabetes, severe preeclampsia/eclampsia or
haemolysis, elevated liver enzymes and low platelet count syn-
drome) [15••], whilst the WHO Fetal Growth Studies included
women with no socioeconomic constraints, normal daily caloric
intakes and normal BMI [32••]. For the Intergrowth 21st Project,
women were selected from urban areas located at low altitudes
(< 1600 m). These areas were free from contaminants such as
pollution, domestic smoke, radiation and other toxic substances.
The definition of a healthy population in this study was: no
clinically relevant past medical history, no history of sexually
transmitted diseases, no history of a previous pregnancy affected
by pre-eclampsia/eclampsia, HELLP syndrome or a related
pregnancy-associated condition, no clinically significant atypical
red cell alloantibodies, negative urinalysis, systolic blood pres-
sure < 140 mmHg and diastolic blood pressure < 90 mmHg and
commenced antenatal care before 14weeks of gestation. Optimal
nutritional status defined as first trimester maternal height (≥
153 cm), body mass index (BMI, ≥ 18.5 and < 30 kg/m2) and
haemoglobin concentration (≥ 110 g/L) without receiving sup-
plements or long-term medications [5••].
We discuss some of the current issues in the development
of foetal growth reference charts and standards in turn as in-
formed by results of the scoping review of studies construct-
ing foetal growth charts since 2012. These issues are by no
means exhaustive but we believe represent some of key issues
attracting debate in this field.
How Charts Are Constructed—Prescriptive Vs
Descriptive Approaches
One of the key differences in foetal growth charts is whether they
are designed to be prescriptive or descriptive. Prescriptive charts
describe the process of producing biological norms or a desirable
target to be achieved or aspired to at individual and population
levels (so as to construct growth standards). Prescriptive stan-
dards show how growth should occur, independent of time and
place [33]. Prescriptive foetal standards refer to tools developed
after carefully sampling healthy populations which have a low
probability of foetal growth restrictions or abnormalities thereby
limiting the effects of nutritional and environmental influences
on growth patterns [4, 34]. The emphasis of these standards is to
characterise optimal foetal growth and how foetuses should grow
in the absence of factors known to affect foetal growth. For
human growth, these are usually based on selected populations
considered to be of optimal health (e.g., adequate nutritional
status and at low risk of abnormal growth) for example the
WHO Multi-centre Growth Reference Study (MGRS) [35••].
Until recently, it was generally accepted that observed differ-
ences in foetal growth were largely due to biological differences
between different regions and ethnicities, resulting in a need for
population-specific charts. This concept has been challenged by
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evidence demonstrating similarities in the genetic makeup of
different non-isolated populations worldwide [36, 37] and more
specifically by recent comparisons finding similarities in early
and late linear foetal growth [38••] in diverse populations.
In contrast, descriptive charts are commonly used to pro-
duce a reference chart that describes the anthropometry of a
given population at a particular time and place, such as a
hospital, region or country. Descriptive reference charts are
usually based on an unselected population with minimal ex-
clusion criteria, for example, known risk factors for optimal
health. Although they are usedmore widely, descriptive charts
are only relevant to the source population. Different popula-
tions will differ in many aspects, such as rates of smoking
during pregnancy, malaria, gestational diabetes and maternal
obesity, which can all affect newborn outcomes. In principle,
following the descriptive approach requires separate reference
charts for each sub-population of interest.
Many descriptive charts are constructed from foetal mea-
surements as a function of gestational age (GA) of the spec-
ified population. An alternative type of descriptive chart is
the customised chart. Customised growth charts are con-
structed following a multivariable analysis that accounts
for maternal factors known to affect foetal growth such as
age, weight, height, BMI, parity, ethnicity, sex of the foetus
etc. or paternal factors such as height [39]. An example of
such a chart is the gestation-related optimal weight curve
(GROW) chart by Gardosi et al. [39, 40••]. Unlike other
foetal growth charts, the development of the customised
charts does not need to exclude women based on their de-
mographics as they are intended to be individualised and
specific for each pregnant woman. The original computer-
generated chart used data from 4179 births from a single
hospital between 1989 and 1990 [40••] by first obtaining
the 10th, 50th and 90th centiles at 40 weeks gestation and
using a mathematical model to determine expected centiles
at earlier gestations. The GROW chart was first constructed
based on a UK population [40••], and the charts have been
used in multiple populations including; Australia [41], the
USA [42] and New Zealand [43].
There is still a debate on whether a unified international
standard can be applied universally irrespective of location
and ethnicity as demonstrated by three large prospective foetal
growth studies published between 2014 and 2017 [5••, 15••,
32••].
We summarise the three studies’ key characteristics and
features:
(1) The INTERGROWTH-21st Project was based on a pre-
scriptive approachwith an aim to construct a single foetal
growth standard for each foetal biometry measurement
for international use despite ethnic differences based on
overwhelming evidence from the WHO-MGRS that
growth amongst healthy populations in diverse
geographica l se t t ings is s imi lar [35•• ] . The
INTERGROWTH-21st Project was a longitudinal study
conducted across eight different geographical settings;
Brazil (Pelotas), China (Beijing), India (Nagpur),
Kenya (Nairobi), Oman (Muscat), UK (Oxford), USA
(Seattle) and Italy (Turin) in healthy populations demon-
strated to have minimal constraints on foetal growth. The
participant selection involved defining free-living popu-
lations in defined geographic areas with evidence of ad-
equate health outcomes in terms of maternal, perinatal
and neonatal morbidity and mortality and then selecting
healthy pregnant women with good nutritional statuses
and low risk of pregnancy complications from the well-
defined populations [44]. The INTERGROWTH-21st
project recruited over 4000 women prospectively for
the construction of foetal standards. The study was con-
ducted prospectively with recruitment carried out in the
first trimester of pregnancy to ensure correct dating of the
pregnancy. Follow-up antenatal ultrasound scans were
performed every 5 weeks (± 1 week) by trained staff with
identical ultrasound machines measuring both skeletal
(head circumference, biparietal diameter, femur length
and occipitofrontal diameter) and fat-based (abdominal
circumference) growth measurement.
(2) The WHO Fetal Growth Study is the foetal component
of the WHO Multicentre Growth Reference Study,
which aimed to establish growth charts for clinical use
based on populations recruited from multiple coun-
tries—a similar aim to INTERGROWTH-21st Project
[32••]. The WHO Fetal Study was a longitudinal pro-
spective study of 1439 women recruited from ten coun-
tries i.e., Argentina, Brazil, Democratic Republic of the
Congo, Denmark, Egypt, France, Germany, India,
Norway and Thai land [32•• ] . Similar to the
INTERGROWTH-21st Project, the study was done pro-
spectively with recruitment of women in the first trimes-
ter between 8 and 13 weeks, who had reliable informa-
tion on their last menstrual period confirmed by an ultra-
sound scan of the crown–rump length. The women were
then scheduled for follow-up ultrasound scans which
were performed monthly. The WHO Fetal Study also
measured both skeletal and fat-based growth measure-
ment of: head circumference, estimated foetal weight,
both femur and humerus length, abdominal circumfer-
ence and biparietal diameter. The WHO Fetal Study fo-
cussed on the estimated foetal weight charts to evaluate
variation due to country, maternal characteristics (age,
height, weight, BMI and parity) and sex of the foetus.
(3) The National Institute of Child Health and Human
Development (NICHD) Fetal Growth Study aimed to
produce race/ethnic-specific foetal growth standards
[15••]. This contradicts the prescriptive concept that
one standard fits all. The study was, however, restricted
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to four self-reported ethnic groups of Asian, Hispanic,
Black and White women in the USA. The study though
prospective in nature, was hospital-based, with women
recruited from 12 centres within the USA, who did not
have any constraints on foetal growth or development. In
total, 2334 women were recruited onto the study, with
analysis performed on 1737 pregnancies. The women
were recruited prospectively in the first trimester con-
firmed by a dating scan and were divided into the afore-
mentioned ethnic groups. The women were then allocat-
ed into an ultrasound schedule that was designed to cap-
ture weekly foetal growth assessment data without sub-
jecting all the women to weekly ultrasound scanning. As
such, each woman attended five follow-up appoint-
ments. Similarly, both skeletal and fat-based measure-
ments were undertaken; crown-rump length, head cir-
cumference, biparietal diameter, abdominal circumfer-
ence and both the femur and humerus length until
delivery.
Attained Size Versus Growth—Utility of Foetal
Growth Charts
There is a subtle difference between the growth of a foetus and
the size of a foetus. In principle, size relates to measurements
at a specific time, whereas growth relates to a change in size
over time. Whilst foetal growth is evaluated from longitudinal
measurements i.e., a series of anthropometric measurements
made of each foetus at multiple time points [45, 46•, 47•, 48•],
foetal size is determined at a single time point [33, 49, 50].
However, the term foetal growth is often used to describe both
of these measurements and is thus sometimes used inappro-
priately [49, 51] as foetuses which are determined to have
abnormal growth may actually be normal in attained size
[45]. Longitudinal studies can therefore be used to produce
both attained size and growth charts which have different in-
terpretations and clinical applications.
Population-Based Sampling Versus Hospital-Based
Sampling
The choice of an appropriate sample and target population is of
great importance as comparisons and inferences applicable to the
general population can be made. The methodology of some of
the studies used to develop foetal growth references sampled
pregnant women from selected hospitals as opposed to sampling
women directly from the population under investigation. The
target population from which the women are selected has impli-
cations on whether the aim is to develop a reference or standard
chart, generalisability and utility of the charts. For example, a
chart based on women who are underweight cannot be applied
to the general population. Hospital-based sampling could be
problematic especially when there are varying levels of health
services available to the population and when healthcare is pro-
vided by more than one health system service as is the case with
several countries [34]. This could also be a potential source of
bias in several low-income countries were a substantial number
of women do not visit hospitals for pregnancy-related monitor-
ing, prenatal and postnatal care.
Period of Inclusion—Pregnancy Dating
The period of inclusion of the women into the study is also an
importantmethodological consideration. For example, during the
first trimester of pregnancy, there is less variability in foetal
growth. Women recruited during this period using the first day
of the last menstrual period could have this information con-
firmed using ultrasonographical evidence by measurement of
the crown-rump length as it has been shown to be most reliable
between 9+0 to 13+6 weeks gestation, but not beyond this range
[52] and considered an essential part of routine antenatal care.
Recruitment after the first trimester, leads to difficulties in ascer-
taining of accurate dating for estimating the expected date of
delivery. A reliable estimate of gestational age is key as it under-
pins clinical care and allows the expected delivery date to be
estimated accurately and also necessary for developing reference
charts. Newborn outcomes such as preterm birth, small-for-GA,
large-for-GA and appropriate-for-GA are all dependent on hav-
ing an accurate estimate of GA.
Study Design—Longitudinal, Cross-sectional
and Mixed Designs
There are many design challenges for studies that aim to con-
struct growth charts from foetal measurements. Foetal growth
charts are designed to either monitor the foetal growth
throughout the pregnancy to allow for medical intervention
if required, or to determine the size of a foetus at a specified
gestational age. Whether a study is longitudinal or cross-
sectional in design is dependent on the question that it is trying
to answer. Study design is of fundamental importance for any
research study as it determines the appropriateness of the
study to address the research question, and it helps inform
the appropriate analysis of the data obtained. Most studies
are based on a cross-sectional design [11] that include only
one examination per foetus whereas a longitudinal design in-
cludes measurements at more than one time [48•]. It is com-
mon to construct size charts from longitudinal data by simply
treating them as cross-sectional, as was done for example in
the WHO Multicentre Growth Reference Study (MGRS)
[35••]. The simplest case is a pure cross-sectional design, for
example, Chitty et al. took one measurement per foetus at a
random time [53]. A longitudinal design based on non-
replicated data at each time point, ought to address correlated
measurements from the same individual.
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In contrast, a mixed design incorporates both longitudinal
and cross-sectional measurements i.e., some participants are
studied longitudinally and others cross-sectionally therefore
for any given participant, the number of measurements includ-
ed may be one or greater. A mixed design can be useful for
studying growth intensively in periods of rapid growth using a
longitudinal design and less intensively in periods of slow
growth using a cross-sectional design. This may be an effi-
cient, cost-effective approach especially for multicentre stud-
ies. An example is the WHO Multicentre Growth Reference
Study (MGRS), which combined a longitudinal study design
from birth to 24 months with a cross-sectional study of chil-
dren aged 18 to 71 months [54]. A mixed design is also likely
to arise when using routine data collected from individuals
requiring close monitoring who are seen more than once.
Statistical Considerations
Appropriate statistical methodology is key to the construction
of foetal growth references and standards. A desirable feature
of foetal charts is that centiles change smoothly with GA, and
that the selected statistical methodology for fitting centiles
provide a good fit to the raw data [46•, 47•, 55]. Some of the
key statistical considerations include: (a) an assessment of
whether the normality assumption is reasonable, as is usually
the case for foetal data conditional on GA; (b) accounting for
the increasing variability with gestation that is typical in foetal
growth data; and (c) a goodness-of-fit assessment with graph-
ical evaluation of the superimposed centiles should be con-
ducted to compare the predictive model to the raw data.
Sample Size
There is very limited literature on what to consider when de-
termining the sample size of foetal growth studies [56–59]. A
systematic review of the methodology used in published ul-
trasound studies for developing size or pregnancy dating
charts found that only 6 of 83 published ultrasound growth
or size charts included their sample size calculations in the
description of their methodology [11, 60].
Sample size calculations can be based on either parametric or
non-parametric methods. Non-parametric methods can be imple-
mented using simulation and bootstrap techniques as has been
demonstrated by Harris et al. [61], Linnet [62] and Jennen-
Steinmetz [58]. Regression-based methods for sample size can
also be evaluated by either non-parametric or parametric ap-
proaches depending on the distribution of the covariate [63, 64].
For example, methods based on regression-based limits are com-
monly used in clinical chemistry studies involving normal refer-
ence ranges [65]. These methods can be adopted and applied in
foetal and neonatal growth studies [66]. Formulae for estimating
sample size for regression-based reference ranges were first pro-
posed by Royston [57] and later extended by Bellera and Hanley
[56]. In 2011, Hanley and Moodie [67] proposed a unified ap-
proach for sample size, precision andpower calculations that con-
siders various studydesigns. Later in 2016,Hanley [59] discusses
sample size considerations for the case of simple and multiple
linear regressions. Regression analysis can be used to obtain ref-
erence limits thataccount for factorssuchasage,genderandparity
with corresponding confidence intervals (CIs) [68–71].
Precision and power are the key factors in the determination
of sample size for constructing reference charts in addition to
study design (longitudinal, cross-sectional or mixed), number
of repeated measurements per individual, existence of replicate
measurements and practicality (cost, time and manpower) [72].
The precision of estimated centiles is inherently variable.
Extreme centiles exhibit large imprecision because there are
few observations at the extreme ends of the distribution, whilst
the median has the greatest precision. For normally distributed
unreplicated data, the standard error of the pth centile is obtained
from the standard formula for the variance of a centile [73]:







where SE is the standard error, SD is the standard deviation of the
measurement (which will increase with GA), zp is the value of
the standard normal distribution corresponding to the pth centile,
and n is the sample size. For example, for the 2.5th or 97.5th
centiles, zp = ±1.96, giving SE = 0.08 SD with a sample size of
500 and 0.03 SD for a sample of 4000. More extreme centiles
will require a larger sample size to estimate than less extreme
ones for the same precision. It is also advisable and common
practice to inflate the calculated sample size by the expected
percentage of attrition for the specific setting.
In general, longitudinal studies are more efficient and have
greater power than cross-sectional studies. Royston (1995) de-
fined this efficiency as the design factor, D, which is the number
of foetuses in a cross-sectional study that would give the same
precision as one foetus in a longitudinal study. He used a simu-
lation study of ultrasound-based biparietal diameter and com-
pared the variance of a centile in longitudinal and equivalent
cross-sectional designs. He calculated the design factor (effect)
to be ~ 2.3 [74]. A longitudinal study thus requires approximately
half to a third the sample size of a cross-sectional study to esti-
mate a given centile with the same precision depending on the
number of measurements per foetus. In the case of subgroups or
multicentre studies, a sufficient power may be required in order
to explore ethnic-specific (i.e., site-specific) charts.
Handling Data from Multiple Sites
Most studies aiming to construct foetal growth references are
done in a single centre. The need for a large sample size and
greater generalisability leads naturally to a multicentre de-
sign, which brings additional challenges. As multicentre
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studies are rare in human growth studies, the combinability
p rob l em i s no t common . Howeve r, t h e MGRS,
INTERGROWTH-21st Project, NICHD and WHO Fetal
Study were multicentre studies and so faced this problem.
Statistical significance is not appropriate for judging
combinability, as even unimportant differences can be statis-
tically significant especially in very large samples.
Assessing how appropriate it is to pool data from multiple
sites is challenging, as a judgement of the similarities in the
foetal growth size patterns across the populations must be
made. The combinability of studies in ameta-analysis is usu-
ally judged qualitatively using the similarity of the studies,
such as the similarity of the participants, interventions and
outcome variables. This is akin to the standardised and care-
ful selectionprocess employedby the studieswhich strives to
ensure similarity of women selected from different sites.
Judgments on similarity of data from different sites depends
on quantifying the differences and variability inherent in the
data for which there is no standard statistical approach for
evaluating what is an acceptable level of agreement.
Some considerations on how to make judgments on simi-
larity of data include: defining a priori threshold of acceptable
differences based on clinical knowledge for judging whether
the differences between the centile curves from each site are
acceptable before conducting the analysis, conducting a sen-
sitivity analysis of the inclusion/exclusion of specific data to
the overall fitted centiles, quantifying the amount of variabil-
ity that can be attributed to site differences and defining a
priori on what differences are considered acceptable based
on clinical impact or meaningfulness.
For example, the INTERGROWTH-21st Project used
the same criterion as the WHO-MGRS where the impact
of the consistency and magnitude of differences in each
site compared to all sites was judged according to Cohen
[75] with differences of 0.5 SD considered to be medium
(an ideological criterion rather than a statistical criterion).
This criterion is also widely used in the assessment and
evaluation of changes in health-related quality of life mea-
sures and patient reported outcomes [76]. Therefore a dif-
ference of 0.5 SD or greater (defined a priori) between the
centile curves from a site and the combined data from all
of the sites at any GA would indicate that the data from
that site were too different to be pooled [55, 77•]. In
addition, a sensitivity analyses involving an assessment
of the impact of excluding each site’s data one at a time
on the overall fitted centiles derived from all the pooled
data is useful in making judgments on whether any single
sites data is incompatible with the rest of the data from
other sites or countries. It is recommended that
multicentre studies should quantify and evaluate the dif-
ferences between their sites using pre-specified criteria, as
was done in the INTERGROWTH-21st Project and the
WHO MGRS study [77•].
Concluding Remarks
In this paper, we have provided a scoping review of studies
constructing charts between 2012 and 2018. The review clearly
demonstrates a lack of consensus on how foetal charts should be
constructed and whether an international chart that can be ap-
plied across populations is feasible. We have discussed some of
the pertinent issues emanating from the review, discussed cur-
rent developments and debates in the construction of foetal ref-
erences and standards. We have highlighted some issues regard-
ing how foetal growth reference charts are constructed (prescrip-
tive and descriptive approaches), and the study design andmeth-
odological considerations for constructing reference centile
charts. Important design features such as inclusion and exclusion
criteria, sample size determination, gestational age (GA) estima-
tion and handling of data from multiple sites for multicentre
studies are seldom well addressed, considered or reported.
Asmany of these charts are in clinical use today and directly
affect the identification of at risk newborns that require treat-
ment and nutritional strategies, the establishment of foetal bio-
metric charts for use require careful methodological consider-
ations. The observations by David Barker in the late 1980s, on
the association between early growth parameters such as birth
weight and the risk of disease in later life [78, 79] leading to the
famous ‘Barker’s hypothesis’ reiterates how crucial and impor-
tant the first 1000 days of life is. They confirmed the already-
overwhelming evidence that foetal growth disorders are risk
factors for adverse perinatal outcomes and can predispose in-
fants to adult chronic diseases [80–84]. These findings on early
foetal programming and associated risk of disease in adulthood
stimulated lots of interest amongst researchers culminating into
the formation of an international society for developmental
origins of health and disease (DOHaD). This is particularly
important as there is still an ongoing debate onwhether a single
growth standard chart can be used internationally [4]. Those
who argue against this suggest significant differences between
racial/ethnic constructs sufficient enough for the production of
racial/ethnic-specific charts for use in foetal growth monitoring
implying a significant influence of a genetic component in
foetal growth patterns existing across ethnicities. Proponents
for a single growth standard for international use argue that
differences observed in foetal growth patterns arise mainly
due to socioeconomic factors like nutritional status and envi-
ronmental exposures [34].
As demonstrated in Table 2, there have been numerous charts
developed for both local (e.g., Liao et al. 2012 [20]), internation-
al (e.g., Papageorghiou et al. [5••] and Kiserud et al. [32••]), as
well as customised use [85]. The current discussion around foetal
growth charts is whether ethnicity plays a role in foetal growth
and therefore whether it should be taken into consideration in the
creation of the charts. A comparison of the INTERGROWTH-
21st Project, NICHD and the WHO-sponsored foetal charts
found that there were minimal differences between the three
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charts in terms of head circumference across gestational ages
[34]. The INTERGROWTH-21st Project constructed charts
from eight diverse populations following similar methodology,
recruitment and standardisation and demonstrated that there was
great similarity in foetal growth amongst healthy women who
were well nourished and lived in good environments. The
NICHD study hypothesised that there are differences in foetal
growth by ethnicity and therefore aimed to construct ethnic spe-
cific charts. Gardosi et al. have always argued for the need of
customised charts that account for a woman’s characteristics that
are known to affect growth such as height, weight and BMI, and
have constructed charts that include these variables.
In summary, we have highlighted some of the current issues
related to the development of foetal references and standards.
The systematic reviewof foetal charts published in the last 5 years
shows that these issues still recur with different opinions on how
these charts should (or should not) be constructed. There is no
consensus on these pertinent issues and hence if not resolvedwill
lead to continued surge of foetal reference and standard charts
which will only exacerbate the current problem of not being able
to make direct comparisons of foetal size and growth across
populations.
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